Alto Neuroscience, Inc. (ANRO) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 7 Buy, 1 Hold.
The consensus price target is $26.33 (low: $16.00, high: $35.00), representing an upside of 3.4% from the current price $25.47.
Analysts estimate Earnings Per Share (EPS) of $-2.59 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-2.50 vs est $-2.59 (beat +3.3%). 2025: actual $-2.19 vs est $-2.24 (beat +2.2%). Analyst accuracy: 97%.
ANRO Stock — 12-Month Price Forecast
$26.33
▲ +3.38% Upside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for Alto Neuroscience, Inc., the average price target is $26.33, with a high forecast of $35.00, and a low forecast of $16.00.
The average price target represents a +3.38% change from the last price of $25.47.
Highest Price Target
$35.00
Average Price Target
$26.33
Lowest Price Target
$16.00
ANRO Analyst Ratings
Buy
Based on 8 analysts giving stock ratings to Alto Neuroscience, Inc. in the past 3 months
EPS Estimates — ANRO
97%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$2.50
vs Est –$2.59
▲ 3.4% off
2025
Actual –$2.19
vs Est –$2.24
▲ 2.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — ANRO
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
